RIMESSI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 7.423
AS - Asia 3.451
EU - Europa 2.512
SA - Sud America 500
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 84
OC - Oceania 19
Totale 14.094
Nazione #
US - Stati Uniti d'America 7.176
SG - Singapore 1.364
CN - Cina 826
IT - Italia 591
DE - Germania 514
VN - Vietnam 396
BR - Brasile 381
UA - Ucraina 273
GB - Regno Unito 240
PL - Polonia 240
HK - Hong Kong 229
FI - Finlandia 173
TR - Turchia 171
CA - Canada 119
SE - Svezia 116
BD - Bangladesh 90
IN - India 89
FR - Francia 86
RU - Federazione Russa 82
JP - Giappone 78
MX - Messico 51
ID - Indonesia 44
AR - Argentina 40
NL - Olanda 39
ZA - Sudafrica 32
IQ - Iraq 30
ES - Italia 29
CO - Colombia 21
LT - Lituania 21
VE - Venezuela 20
AT - Austria 19
BE - Belgio 18
PH - Filippine 18
PK - Pakistan 17
CZ - Repubblica Ceca 16
AU - Australia 15
CR - Costa Rica 13
TN - Tunisia 13
UZ - Uzbekistan 13
SA - Arabia Saudita 12
CL - Cile 11
EC - Ecuador 11
HN - Honduras 11
SV - El Salvador 11
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
MA - Marocco 9
MY - Malesia 9
EG - Egitto 8
IE - Irlanda 8
JM - Giamaica 8
JO - Giordania 8
DZ - Algeria 7
IR - Iran 7
NP - Nepal 7
PR - Porto Rico 7
PY - Paraguay 7
KE - Kenya 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
CW - ???statistics.table.value.countryCode.CW??? 5
LB - Libano 5
AZ - Azerbaigian 4
BO - Bolivia 4
EE - Estonia 4
RO - Romania 4
BB - Barbados 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
SI - Slovenia 3
TW - Taiwan 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BH - Bahrain 1
CD - Congo 1
CM - Camerun 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
Totale 13.978
Città #
Ashburn 876
Singapore 841
San Jose 596
Fairfield 460
Woodbridge 437
Chandler 378
Houston 352
Beijing 317
Council Bluffs 285
Santa Clara 278
Jacksonville 273
Munich 262
Warsaw 235
Ann Arbor 231
Hong Kong 223
Seattle 176
Wilmington 153
Los Angeles 150
New York 138
Cambridge 134
Ho Chi Minh City 122
Izmir 92
Nanjing 81
Milan 77
Dallas 76
Hanoi 76
Helsinki 76
Tokyo 74
Princeton 68
Shanghai 54
Buffalo 53
Lauterbourg 52
São Paulo 52
London 51
Ferrara 49
San Diego 47
Boardman 41
Bologna 38
Orem 38
Turku 37
Montreal 35
Brooklyn 33
Phoenix 33
Rome 33
Bremen 32
Mexico City 32
Da Nang 30
Tianjin 30
Chicago 29
Jakarta 29
Toronto 29
Denver 28
Hefei 28
Dearborn 27
Atlanta 26
Falkenstein 26
Stockholm 25
Frankfurt am Main 22
Johannesburg 22
San Mateo 22
The Dalles 22
Naples 20
Poplar 20
Chennai 19
Washington 19
Brussels 18
Falls Church 18
Haiphong 18
Changsha 17
San Francisco 16
Hebei 15
Jiaxing 15
Nanchang 15
Brasília 13
North Bergen 13
Philadelphia 13
Shenyang 13
Amsterdam 12
Mumbai 12
Reggio Emilia 12
Rio de Janeiro 12
Tashkent 12
Brno 11
Charlotte 11
Guangzhou 11
Moscow 11
San José 11
San Salvador 11
Auburn Hills 10
Baghdad 10
Florence 10
Norwalk 10
Ottawa 10
Boston 9
Hangzhou 9
Istanbul 9
Ningbo 9
Nuremberg 9
Cleveland 8
Des Moines 8
Totale 9.141
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 438
Un'ipotonia sospetta 413
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 338
A Family with γ-Thalassemia and High Hb A2 Levels 314
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 298
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 295
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 288
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 285
GENETIC, CLINICAL AND NEUROPATHOLOGICAL INSIGHTS INTO PATIENTS WITH ASCERTAINED DIAGNOSIS OF HUNTINGTON DISEASE 285
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 280
Exon skipping-mediated dystrophin reading frame restoration for small mutations 279
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin gene 265
International-DMD (IDMD): a PTC Therapeutics-supported diagnostic project to widely identify Dystrophin mutations by NGS technologies 253
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 250
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point 247
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 239
Commercial kit-based diagnosis is not enough for prenatal testing of beta-thalassemia: pitfalls in diagnostic mutation analysis raises the need for reference laboratories 237
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 237
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 231
Characterization of a 4-Mb region at chromosome 6q21 harboring a replicative senescence gene 228
Exon Skipping Quantification by Real-Time PCR 228
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 225
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human 223
Antisense oligonucleotides capable of inducing exon skipping in dystrophin gene and their use in treatment of duchenne muscular dystrophy 223
Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1) 219
Transcriptional behavior of DMD gene duplications in DMD/BMD males 218
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 213
Can paranasal sinus computed tomography screen for cystic fibrosis heterozygotes? 213
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 212
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 209
Characterization of BKV variants rescued from human tumors and tumor cell lines 202
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 201
DMD gene molecular genetic characterization in Eastern Europe and non European countries 200
Systemic Expression of HIV-1 tat Gene in Transgenic Mice Induces Endothelial Proliferation and Ibmors of Different Histotypes 198
Preclinical PK and PD studies on 2′-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model 197
Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: In vitro mimicking and antisense modulation of the splicing abnormality 192
Transformation of human cells by recombinant DNA molecules containing BK virus early region and the human activated c-Hras or c-myc oncogenes 190
Uso di modelli di trasformazione virale nello studio dei geni oncosoppressori tramite trasferimento monocromosomico. 189
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 189
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 187
In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy 185
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 184
Genetic analysis of a 6q21 region harboring a senescence gene: construction of a 4 megabase yeast artificial chromosome contig 183
Tempo and mode of evolution of a primate-specific retrotransposon belonging to the LINE 1 family. 179
La consulenza oncogenetica per il carcinoma mammario ed ovarico con ricorrenza familiare come parte di un Percorso integrato multidisciplinare. 175
Workload measurement for molecular genetics laboratory: A survey study 175
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 174
Localizzazione preliminare di tumor suppressor genes mediante chromosome transfer. 167
Tumorigenicity and anchorage-independent growth suppression of BK virus transformed mouse cells by human chromosome 11 166
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 164
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 161
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 157
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 156
Brody disease: Insights into biochemical features of SERCA1 and identification of a novel mutation 154
Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular distrophy 144
Nanoparticle of the core-​shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy 144
Tumor suppressor genes. New perspectives for clinical investigations in cancer 133
null 131
Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation. 131
Presence of HHV-8 DNA in semen of immunocompetent HIV-negative individuals from different geographical areas in Italy. 129
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 128
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 125
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. 124
Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients 122
null 99
null 92
null 90
null 90
Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion. 83
Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B costitutively expressed in human cells with a BK virus episomal vector 79
null 42
Totale 14.094
Categoria #
all - tutte 60.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.633
Totale 62.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022573 0 0 0 0 50 27 38 34 27 42 79 276
2022/2023801 72 81 20 111 167 100 40 66 87 8 35 14
2023/2024478 37 66 29 8 33 123 20 38 9 13 8 94
2024/20252.004 44 30 139 85 242 179 113 102 410 158 266 236
2025/20265.038 533 185 386 654 771 351 688 236 406 514 194 120
2026/20271.398 134 248 496 516 4 0 0 0 0 0 0 0
Totale 14.094